Prevalence of diabetic foot and its risk factors in the State of Espirito Santo, Brazil

Authors

  • Wendel Jose Teixeira Costa a Programa de Mestrado em Políticas Públicas e Desenvolvimento Local, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. b Laboratório de Escrita Científica, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. c Laboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário Saúde ABC (CUSABC) Convênio Acre/FMABC-007/2015, Santo André/ São Paulo, 09060-870, Brasil. d Laboratório de Escrita Científica, Centro Universitário de Caratinga(UNEC), Caratinga/ Minas Gerais, 35300-345, Brasil.
  • Thaiany Pedrozo Campos Antunes b Laboratório de Escrita Científica, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. cLaboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário FMABC Convênio Acre/FMABC-007/2015, Santo André/ São Paulo, 09060-870, Brasil.
  • Luiz Carlos de Abreu a Programa de Mestrado em Políticas Públicas e Desenvolvimento Local, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. b Laboratório de Escrita Científica, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. c Laboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário Saúde ABC (CUSABC) Convênio Acre/FMABC-007/2015, Santo André/ São Paulo, 09060-870, Brasil. e Universidade Federal do Acre (UFAC), Rio Branco/ Acre, 69.915-900, Brasil. g Graduate Entry Medical School, University of Limerick, Limerick, V94 T9PX, Ireland.
  • José Lucas Souza Ramos a Programa de Mestrado em Políticas Públicas e Desenvolvimento Local, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. b Laboratório de Escrita Científica, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. c Laboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário FMABC, Convênio Acre/FMABC-007/2015, Santo André/ São Paulo, 09060-870, Brasil.
  • Jonathan Mende de Castro d Laboratório de Escrita Científica, Centro Universitário de Caratinga(UNEC), Caratinga/ Minas Gerais, 35300-345, Brasil.
  • João Batista Francalino da Rocha c Laboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário FMABC, Convênio Acre/FMABC-007/2015, Santo André/ São Paulo, 09060-870, Brasil. e Universidade Federal do Acre (UFAC), Rio Branco/ Acre, 69.915-900, Brasil.
  • Nilson Penha-Silva h Universidade Federal de Uberlânida. Instituto de Biotecnologia. Uberlândia, Minas Gerais, Brasil.
  • Italla Maria Pinheiro Bezerra a Programa de Mestrado em Políticas Públicas e Desenvolvimento Local, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. b Laboratório de Escrita Científica, Escola Superior de Ciências da Santa Casa de Misericórdia (EMESCAM), Vitória/ Espírito Santo, 29045-402, Brasil. c Laboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário FMABC, Convênio Acre/FMABC-007/2015, Santo André/ São Paulo, 09060-870, Brasil. e Universidade Federal do Acre (UFAC), Rio Branco/ Acre, 69.915-900, Brasil. f Programa de Mestrado em Ciências da Saúde da Amazônia, Bolsista CAPES Brasil, Universidade Federal do Acre (UFAC), Rio Branco/ Acre, 69.915-900, Brasil.

DOI:

https://doi.org/10.36311/jhgd.v33.14295

Keywords:

Diabetes Mellitus., Diabetic foot, Prevalence Epidemiology

Abstract

Introduction: Diabetic Foot (DF) is the leading cause of non-traumatic amputations in Western countries, causing death or physical and mental disability, poor quality of life and high cost to society.

Objetive: To analyze the prevalence of DF and related risk factors in the diabetic population residing in Espírito Santo State, Brazil.

Methods: Cross-sectional, descriptive study with time series design, using secondary data on morbidity of individuals with DF living in the State of Espírito Santo, registered and followed by the Hypertensive and Diabetic Registration and Monitoring System.

Results: From 64,196 diabetic patients, 3.9% had Type 1 DM, 10.9% Type 2 DM and 85.2% had hypertension. The prevalence of DF was 2.9% in type 1 DM, 3.3% in type 2 DM and 4.5% in DM with hypertension. Higher rates of DF were observed in males, aged over 60 years in type 1 and type 2 DM, and up to 19 years in DM with hypertension, smoking, sedentary lifestyle, Acute Myocardial Infarction (AMI), stroke and Cronic Kidney disease (CKD). In overweight individuals, the prevalence of DF was higher only in type 1 DM. There was a significant association in all variables except overweight in both types of DM, sedentary lifestyle and stroke in type 1 DM.

Conclusion: Findings showed important prevalence of DF, with higher concentration in men older than 60 years, on smoking, sedentary lifestyle, AMI, stroke and CKD, with significant statistical association in the analized variables, except for overweight in both types of DM, as well as sedentary lifestyle and stroke in type 1 DM.

Downloads

Download data is not yet available.

References

International Diabetes Federation. Diabetes Atlas. 8th ed. Brussels. https://diabetesatlas.org/resources/2017-atlas.html (2017). Acessed on Mar 2nd 2019.

WHO. World Health Organization. Global Report on Diabetes. http://www.who.int/mediacentre/factsheets/fs312/en/ (2016). Acessed on Aug 16th 2018.

López-Jaramillo P, Sánchez RA, Diaz M, Cobos L, Parra-Carrillo BAJZ, Lizcano F, Lanas F, Sinay I, Sierra ID, Peñaherrera E, Bendersky M, Schmid H, Botero R, Urina M, Lara J, Foss MC, Márquez G, Harrap S, Ramírez AJ, Zanchetti A. Consenso latino-americano de hipertensão em pacientes com diabetes tipo 2 e síndrome metabólica. Arq Bras Endocrinol Metab. 2014; doi: http://dx.doi.org/10.1590/0004-2730000003019.

BRASIL. Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes 2017-2018. https://www.diabetes.org.br/profissionais/images/2017/diretrizes/diretrizes-sbd-2017-2018 (2018). Accessed on Mar 2nd 2019.

Santos MAS, Oliveira MM, Andrade SSCA, Nunes ML, Malta DC, Moura L. Tendências da morbidade hospitalar por doenças crônicas não transmissíveis no Brasil, 2002 a 2012. Epidemiol. Serv. Saúde. 2015; doi: 10.5123/S1679-49742015000300005.

Apelqvist J, Bakker K, Houtum WH, Nabuurs-Franssen MH, Schaper NC. International Consensus and Practical Guidelines on the Management and the Prevention of the Diabetic Foot. Diabetes Metab Res Rev. 2000; doi: https://doi.org/10.1002/1520-7560(200009/10)16:1.

Ocampo-Barrio P, Landeros-González D, Rojas LRM. Frecuencia de depresión en pacientes con y sin pie diabético. Semergen. 2010; doi: https://doi.org/10.1016/j.semerg.2010.04.010.

Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, Jirkovska A, Piaggesi A, Ragnarson-Tennvall G, Reike H, Spraul M, Acker KV, Baal JV, Merode FV, Ferreira I, Huijberts M. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. Diabetologia. 2008; doi: 10.1007/s00125-008-0940-0.

Tavares DMS, Dias FA, Araújo LR, Pereira GA Perfil de clientes submetidos a amputações relacionadas ao diabetes mellitus erfil de clientes submetidos a amputações relacionadas ao diabetes mellitus. Rev Bras Enferm. 2009; doi: http://dx.doi.org/10.1590/S0034-71672009000600004.

Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The Global Burden of Diabetic Foot Disease. Lancet. 2005; doi: 10.1016/S0140-6736(05)67698-2.

Battum PV, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, Acker KV, Baal JV, Ferreira I, Huijberts M. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med. 2011; doi: 10.1111/j.1464-5491.2010.03192.x.

Oliveira SLC, filho WDL. AIDS e Diabetes Mellitus Versus Justiça Distributiva no Sistema Público de Saúde. Rev Bras Enferm. 2004; doi: org/10.1590/S0034-71672004000600025.

BRASIL. Ministério da Saúde. Portaria nº 2.436. http://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html (2017). Acessado em 2 de mar 2019.

Zangirolami-Raimundo J, Echeimberg JO, Leone C. Researchmethodologytopics: Cross sectional studies. Journal of Human Growth and Development. 2018; doi: http://dx.doi.org/10.7322/jhgd.152198.

BRASIL. Ministério da Saúde. Portaria Nº 371. http://bvsms.saude.gov.br/bvs/saudelegis/gm/2002/prt0371_04_03_2002_rep.html (2002). Acessado em 2 de mar 2019.

BRASIL. Ministério da Saúde. Portaria Nº 235. http://bvsms.saude.gov.br/bvs/saudelegis/gm/2001/prt0235_20_02_2001.html (2001). Acessado em 2 de mar 2019.

Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals Of Medicine. 2017; doi: 10.1080/07853890.2016.1231932.

Wolf G, Müller N, Busch M, Eidner G, Kloos C, Hunger-Battefeld W, Müller UA. Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association. Nephrol Dial Transplant. 2009; doi: 10.1093/ndt/gfn724.

Vieira-Santos ICR, Souza WV, Carvalho EF, Medeiros MCWC, Nóbrega MGL, Lima PMS. Prevalência de pé diabético e fatores associados nas unidades de saúde da família da cidade do Recife, Pernambuco, Brasil, em 2005. Cad. Saúde Pública. 2008; doi: http://dx.doi.org/10.1590/S0102-311X2008001200015.

Bondar AC, popa AR. Diabetic Neuropathy Prevalence and Its Associated Risk Factors in Two Representative Groups of Type 1 and Type 2 Diabetes Mellitus Patients from Bihor County. Maedica (Buchar). 2018; doi: 10.26574/maedica.2018.13.3.229.

Rathsman B, Jensen-Urstad K, Nyström T. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study. Diabetologia. 2014; doi: 10.1007/s00125-014-3248-2.

Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; doi: 10.1136/bmj.321.7258.412.

BRASIL. IBGE – INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA. Pesquisa Nacional de Saúde 2013: percepção do estado de saúde, estilos de vida e doenças crônicas. Rio de Janeiro: IBGE, 2014.

Alonso-Fernándeza M, Mediavilla-Bravob JJ, López-Simarroc F, Comas-Samperd JM, Carramiñana-Barrerae F, Mancera-Romerof J, Nocitog AS. Evaluation of diabetic foot screening in Primary Care. Endocrinol Nutr. 2014; doi: 10.1016/j.endoen.2014.06.008.

Goie TT, Naidoo M. Awareness of diabetic foot disease amongst patients with type 2 diabetes mellitus attending the chronic outpatients department at a regional hospital in Durban, South Africa. Afr J Prim Health Care Fam Med. 2016; doi: 10.4102/phcfm.v8i1.1170.

Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, Van Baal J, Van Merode F, Schaper N. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med. 2008; doi: 10.1111/j.1464-5491.2008.02445.x.

Rossaneis MA, Haddad MD, Mantovani MF, Marcon SS, Pissinati PS. Foot ulceration in patients with diabetes: a risk analysis. Br J Nurs. 2017; doi: 10.12968/bjon.2017.26.6.S6.

Monteiro-Soares H, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Ver. 2012; doi: 10.1002/dmrr.2319.

Tang ZQ, Chen HL, Zhao FF. As diferenças de género de menor risco de amputação de membros em pacientes com pé diabético: a meta-análise. Int J Feridas Baixa Extrem. 2014; doi: https: //dx.doi. org / 10,1177 / 1534734614545872.

Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of international working group on diabetic foot. Pak J Med Sci. 2013; doi: http://dx.doi.org/10.12669/pjms.293.3473.

Sarfo-Kantanka O, Sarfo FS, Kyei I, Agyemang C, Mbanya JC. Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010-2015- a retrospective cohort study. BMC Endocr Disord. 2019; doi: 10.1186/s12902-019-0353-8.

Namayandeh SM, Karimi A, Fallahzadeh H, Rahmanian M, SadrBafghi SM, Soltani M, Hadiani L. The incidence rate of diabetes mellitus (type II) and its related risk factors: A 10-year longitudinal study of Yazd Healthy Heart Cohort (YHHC), Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; https://doi.org/10.1016/j.dsx.2019.02.012.

Darivemula S, Nagoor K, Patan SK, Reddy NB, Deepthi CS, Chittooru CS. Prevalence and Its Associated Determinants of Diabetic Peripheral Neuropathy (DPN) in Individuals Having Type-2 Diabetes Mellitus in Rural South India. Indian J Community Med. 2019; doi: 10.4103/ijcm.IJCM_207_18.

O’Hare JA, Abuaisha F, Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci. 1994; 163:132–5. PMID: 8200777.

Reindel J, Zander E, Heinke P, Kohnert KD, Allwardt C, Kerner W. (2004). Metabolisches Syndrom bei Patienten mit Diabetes mellitus Typ 1. Herz. 2004; doi:10.1007/s00059-004-2606-0.

Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013; doi: 10.1111/dme.12196.

Bortoletto MS, Andrade SM, Matsuo T, Haddad MCL, González AD, Silva AMR. Risk factors for foot ulcers--a cross sectional survey from a primary care setting in Brazil. Prim Care Diabetes. 2014; doi:

Sayah F, Soprovich A, Qiu W, Edwards AL, Johnson JA. Diabetic Foot Disease, Self-Care and Clinical Monitoring in Adults with Type 2 Diabetes: The Alberta’s Caring for Diabetes (ABCD) Cohort Study. Can J Diabetes. 2015; doi: 10.1016/j.jcjd.2015.05.006.

Nakanishi N, Nakamura K, Matsuo Y, Suzuki K, Tatara K. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med. 2000; doi: 10.7326/0003-4819-133-3-200008010-00009.

Clair C, Rigotti NA, Meigs JB. Smoking cessation, weight change, and risk of cardiovascular disease--reply. JAMA. 2013; doi: 10.1001/jama.2013.7945.

Jang JJ, Bhapkar M, Coles A, Vemulapalli S, Fordyce CB, Lee KL, Udelson JE, Hoffmann U, Tardif JC, Jones WS, Mark DB, Sorrell VL, Espinoza A, Douglas PS, Patel MR. Predictive Model for High-Risk Coronary Artery Disease. Circulation: Cardiovascular Imaging. 2019; doi: https://doi.org/10.1161/CIRCIMAGING.118.007940.

Mutie PM, Giordano GN, Franks PW. Lifestyle precision medicine: the next generation in type 2 diabetes prevention?. BMC Med. 2017; doi: 10.1186/s12916-017-0938-x.

Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2017; doi: 10.1016/S2213-8587(17)30183-3.

Criqui MH, Aboyans V. Epidemiology of Peripheral Artery Disease. Circ. Res. 2015; doi: 10.1161/CIRCRESAHA.116.303849.

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010; doi: 10.2337/dc10-1303.

Callaghan BC. Little AA, Feldman EL, Hughes RA. Enhanced Glucose Control for Preventing and Treating Diabetic Neuropathy. Cochrane Database Syst Rev. 2012; doi: 10.1002/14651858.CD007543.pub2.

Russell JW, Zilliox LA. Diabetic neuropathies. Continuum (Minneap Minn). 2014; doi: 10.1212/01.CON.0000455884.29545.d2.

Pires MR, Bani RCF, Lima GZ, Haddad MIR, Takamoto PM, Pires LAR, Manganaro MM, Croscioli MRFB, Fernani DCGL, Vanderlei LCM, Freire APCF, Pacagnelli FL. Problems with adherence to treatment among adolecents with diabetes mellitus type 1. J Hum Growth Dev. 2016; doi: http://dx.doi.org/10.7322/jhgd.110023.

Bezerra IMP, Machado MFAS, Souza OF, Antão JYFL, Dantas MNL, Reis AOA, Martins AAA, Abreu LC. Professional activity in the context of health education:a systematic review. Journal of Human Growth and Development. 2014; doi: dx.doi.org/10.7322/jhdg.88909.

Atrash HK, Carpentier R. The evolving role of public healthin the delivery of health care. Journal of Human Growth and Development. 2012; doi: https://doi.org/10.7322/jhgd.46349.

Bezerra IMP, Sorpreso ICE. Concepts and movements in health promotion to guide educational practices. J Hum Growth Dev 2016. Doi: http://dx.doi.org/10.7322/jhgd.113709.

Downloads

Published

2023-03-23

Issue

Section

ORIGINAL ARTICLES